AI & Machine Learning

A top luxury planner is trading Zoom calls for Swiss Alps adventures, letting couples "test-drive" their destination wedding before they say "I do."

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

Oulin's new AI Smart Sink, unveiled at CES 2026, uses a large language model to identify food, find recipes, and guide you through cooking.

The Midwestern 'Modern General Store' earns top national honors for its website and in-store service, revealing a powerful hybrid retail strategy.

A Texas firm delivered 1.9M tons of carbon removals via ranching, paying farmers millions and showing how soil can be a powerful climate solution.

With a new board appointment and $19M in funding, Enhanced Genomics is leveraging its 3D genomics platform to build its own pipeline of precision therapies.

Amazon Pharmacy now offers the new Wegovy pill with transparent cash-pay options, shaking up the high-demand weight management drug market.

With 10,000+ registered, FastBull's free gold trading contest is a hit. But is it a path to real skill or a gamified pipeline for brokers?

With a new Deputy CEO and CFO, newcleo accelerates its mission to power the world with recycled nuclear waste, reshaping the global energy landscape.

CVS Health is set to reveal its 2025 results. Will its integrated strategy pay off amid rising costs, PBM scrutiny, and a key Aetna turnaround?

Automated Industrial Robotics Inc. acquires Ireland's KAON Automation, a strategic move to dominate the high-stakes medical and life sciences market.

Office leasing rose 5% in 2025, but a closer look reveals a fractured recovery, with tech hubs booming while others lag and companies shrink their footprints.

Prescient's acquisition of Uptake creates an integrated giant in healthcare consulting. What does this mean for the industry, clients, and patient outcomes?

At CES 2026, Jinxin Technology unveiled NAMI INSIGHT One, AI-powered learning glasses aiming to revolutionize education. But can it overcome the hurdles?

With new funding, Major Medical Devices is advancing a novel AAA repair device that uses arm access, promising safer procedures and wider patient eligibility.

Akari Therapeutics is advancing a new class of cancer drugs. Its unique PH1 payload kills tumors and activates the immune system, setting up a pivotal 2026.

With a new $1.6B valuation led by T. Rowe Price, Hadrian is scaling its AI-powered factories to spearhead America's industrial and defense resurgence.

After a year of scrutiny, a former Urban League leader invests in the aspiring minority-controlled stock exchange, validating its mission for structural change.

A new collaboration between the Global Alzheimer's Platform and Alamar Biosciences aims to revolutionize diagnosis with ultra-sensitive blood tests for all.

Amid rising regulatory pressure, dxFeed's flawless performance in a critical industry-wide disaster recovery test sets a new benchmark for data reliability.